Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Fleming

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Cell Reports|February 7, 2019
Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic TumorsSahil Seth, Chieh-Yuan Li, I-Lin Ho, et al.
Journal of the National Cancer Institute|June 14, 2025
Multidisciplinary evidence-based consensus statements on salvage surgery for recurrent head and neck cancer (International Centre for Recurrent head and neck Cancer)Andrew Williamson, Grainne Brady, Natalie Harris, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Spectrum of somatic mutational features of colorectal tumors in ancestrally diverse populationsMarco Matejcic, Jamie K Teer, Hannah J Hoehn, et al.
Research Square|February 24, 2025
Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinomaJennifer Permuth, Margaret Park, Evan Davis, et al.
Science (New York, N.Y.)|September 16, 2017
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabineLeore T Geller, Michal Barzily-Rokni, Tal Danino, et al.
Frontiers in Oncology|August 7, 2024
Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinomaJennifer B Permuth, Margaret A Park, Dung-Tsa Chen, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Cell Reports|February 7, 2019
Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic TumorsSahil Seth, Chieh-Yuan Li, I-Lin Ho, et al.
Journal of the National Cancer Institute|June 14, 2025
Multidisciplinary evidence-based consensus statements on salvage surgery for recurrent head and neck cancer (International Centre for Recurrent head and neck Cancer)Andrew Williamson, Grainne Brady, Natalie Harris, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2024
Spectrum of somatic mutational features of colorectal tumors in ancestrally diverse populationsMarco Matejcic, Jamie K Teer, Hannah J Hoehn, et al.
Research Square|February 24, 2025
Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinomaJennifer Permuth, Margaret Park, Evan Davis, et al.
Science (New York, N.Y.)|September 16, 2017
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabineLeore T Geller, Michal Barzily-Rokni, Tal Danino, et al.
Frontiers in Oncology|August 7, 2024
Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinomaJennifer B Permuth, Margaret A Park, Dung-Tsa Chen, et al.
Pageof 5